Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Certest – Rapid Tests Portfolio

Certest Immunodiagnostic is committed to providing a comprehensive portfolio of diagnostic reagents for detecting infectious diseases and different markers, covering different needs of formats, types of use, throughput, precision, and time from sample to result.

Certest Rapid Test – One-step immunochromatographic tests

Fast | Easy | Reliable | Simple

Our products are the result of years of experience detecting the presence of antigens with the lateral flow immunochromatographic technique.

The devices are based on the coloured latex particles. Showing results on bands of different colours facilitates the interpretation of the result.

Certest Lateral Flow Immunochromatography portfolio mainly covers the diagnostic of gastrointestinal*, respiratory infectious diseases and the detection of inflammatory or tumor markers in the Gastrointestinal tract.

Benefits of Certest Rapid Tests:

  • Single device, multiple tests from one sample.
  • One sample, one preparation, panel testing.
  • Multiple analytes diagnosed in 10 minutes.
  • Reduced risk of sample and result mishandling.
  • Operational efficiency.

Certest Rapid Test Brochure

Download >

* IVD version is not available for general supply unless it is first included on the Australia Register of Therapeutic Goods (ARTG)

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.



Request a Quote

Request Quote

Recent Posts

Fungal Infection – Assays and Controls*

IMMY | Vircell IMMY’s rapid fungal assays and Vircell’s external controls deliver reliable, room temperature diagnostics with built-in quality assurance for streamlined serology workflows. Vircell…

Read full article

Vircell – VirClia Extraction Tube

Discover Vircell’s VirClia Extraction Tube, an innovative pre-dispensed tube featuring a one-step filtering process that eliminates the need for centrifugation, thereby significantly simplifying the pre-analytical…

Read full article

Advancing Sepsis Diagnostics—Journal of Clinical Medicine (JCM), Honors SeptiCyte RAPID* Study

  Immunexpress are delighted to announce that the study, “Validation of SeptiCyte® RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation,” has been selected as an Editor’s Choice Paper for 2024 by the Journal of Clinical Medicine (JCM) MDPI Editorial Team. This honour…

Read full article